DSE : AFCAGRO
AFC Agro Biotech Limited — Key statistics
Medicinal Chemicals and Botanical Products · Bangladesh
Last price 4.8 BDT (At close: Oct 29, 2026) · Market cap 553.04M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Technical report: trend, RSI, support and resistance, charts
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 553.04M |
| Enterprise Value | n/a |
Dates
| Measure | Value |
|---|
| Earnings Date | Dec 24, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 115.22M |
| Shares Outstanding | 115.22M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +31.41% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Ratios
| Measure | Value |
|---|
| PE Ratio | 698.28 |
| Forward PE | n/a |
| PS Ratio | 1.27 |
| PB Ratio | 0.26 |
| P/TBV Ratio | 0.26 |
| P/FCF Ratio | 36.93 |
| P/OCF Ratio | 7.53 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 6.02 |
| Quick Ratio | 3.03 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | 1.12 |
| Debt / FCF | 26.08 |
| Interest Coverage | 1.02 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 0.04% |
| Return on Assets (ROA) | 0.88% |
| Return on Invested Capital (ROIC) | 1.48% |
| Return on Capital Employed (ROCE) | 1.55% |
| Weighted Average Cost of Capital (WACC) | 6.62% |
| Revenue Per Employee | 2.40M |
| Profits Per Employee | 4,419 |
| Employee Count | 181 |
| Asset Turnover | 0.17 |
| Inventory Turnover | 0.79 |
Taxes
| Measure | Value |
|---|
| Income Tax | 20,399 |
| Effective Tax Rate | 2.49% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.14 |
| 52-Week Price Change | -15.79% |
| 50-Day Moving Average | 5.95 |
| 200-Day Moving Average | 6.58 |
| Relative Strength Index (RSI) | 26.16 |
| Average Volume (20 Days) | 61,027 |
Shortselling
| Measure | Value |
|---|
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Incomestatement
| Measure | Value |
|---|
| Revenue | 434.50M |
| Gross Profit | 118.19M |
| Operating Income | 36.39M |
| Pretax Income | 820,272 |
| Net Income | 799,873 |
| EBITDA | 349.04M |
| EBIT | 36.39M |
| Earnings Per Share (EPS) | 0.01 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 96.98M |
| Total Debt | 390.59M |
| Net Cash | -293.61M |
| Net Cash Per Share | -2.55 |
| Equity (Book Value) | 2.11B |
| Book Value Per Share | 18.33 |
| Working Capital | 1.19B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 73.42M |
| Capital Expenditures | -58.44M |
| Depreciation & Amortization | 312.65M |
| Net Borrowing | 12.89M |
| Free Cash Flow | 14.98M |
| FCF Per Share | 0.13 |
Margins
| Measure | Value |
|---|
| Gross Margin | 27.20% |
| Operating Margin | 8.38% |
| Pretax Margin | 0.19% |
| Profit Margin | 0.18% |
| EBITDA Margin | 80.33% |
| EBIT Margin | 8.38% |
| FCF Margin | 3.45% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | 0.05 |
| Dividend Yield | 1.04% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 101.07% |
| FCF Payout Ratio | n/a |
| Buyback Yield | -2.99% |
| Shareholder Yield | -1.95% |
| Earnings Yield | 0.14% |
| FCF Yield | 2.71% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Dec 22, 2019 |
| Split Type | Forward |
| Split Ratio | 1.1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 4.77 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |